PH21026A - Cephalosporin derivatives, its pharmaceutical formulation and method of use thereof - Google Patents
Cephalosporin derivatives, its pharmaceutical formulation and method of use thereofInfo
- Publication number
- PH21026A PH21026A PH30018A PH30018A PH21026A PH 21026 A PH21026 A PH 21026A PH 30018 A PH30018 A PH 30018A PH 30018 A PH30018 A PH 30018A PH 21026 A PH21026 A PH 21026A
- Authority
- PH
- Philippines
- Prior art keywords
- denotes
- see diagramm
- radical
- group
- acid addition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fats And Perfumes (AREA)
- Control Of Electric Motors In General (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
1. Claims (for the Contracting States : BE, CH, DE, FR, GB, IT, LU, LI, NL, SE) A cephem derivative of the formula I see diagramm : EP0111934,P10,F3 and physiologically acceptable acid addition salts thereof in which R**1 denotes C1 -C2 -alkyl, R**2 denotes a pyridinium radical see diagramm : EP0111934,P10,F4 which is substituted by 2 alkyl groups in the ortho-position which are linked to form a trimethylene to pentamethylene ring in which one carbon atom can be replaced by an oxygen atom, or denotes a 1-quinolinium radical or a 2-isoquinolinium radical and in which the R**1 O group is in the syn-position. 1. Claims (for the Contracting State AT) A process for the preparation of a cephem derivative of the formula I see diagramm : EP0111934,P11,F4 and physiologically acceptable acid addition salts thereof in which R**1 denotes C1 -C2 -alkyl, R**2 denotes a pyridinium radical see diagramm : EP0111934,P12,F1 which is substituted by 2 alkyl groups in the ortho-position which are linked to form a trimethylene to pentamethylene ring in which one carbon atom can be replaced by an oxygen atom, or denotes a 1-quinolinium radical or a 2-isoquinolinium radical in which the R**1 O group is in the syn-position which comprises a) reacting a compound of the general formula II see diagramm : EP0111934,P12,F2 or salts thereof or a reactive derivative of the compound II in which R**1 has the meaning mentioned above and R**7 denotes an amino group or a protected amino group and R**8 denotes a group which can be replaced by the pyridine, quinoline or isoquinoline derivatives corresponding to the radicals R**2 of the formula I, with these pyridine, quinoline or isoquinoline derivatives, and alpha) splitting off a protective group which may be present and beta) if necessary, converting the resulting product into a physiologically acceptable acid addition salt, or b) reacting a 7-aminocephem compound of the general formula III see diagramm : EP0111934,P12,F3 or acid addition salts thereof in which R**2 has the abovementioned meaning and in which the amino group can also be present in the form of a reactive derivative, with a 2-(5-amino-1,2,4-thiadiazol-3-yl)-2-synoximinoacetic acid of the general formula IV see diagramm : EP0111934,P12,F4 in which R**1 and R**7 have the meaning mentioned above, or with an activated derivative of this compound, and alpha) splitting off a protective group which may be present, and beta) if necessary, converting the resulting product into a physiologically acceptable acid addition salt.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823247613 DE3247613A1 (en) | 1982-12-23 | 1982-12-23 | CEPHALOSPORINE DERIVATIVES AND METHOD FOR THEIR PRODUCTION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH21026A true PH21026A (en) | 1987-06-30 |
Family
ID=6181484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH30018A PH21026A (en) | 1982-12-23 | 1983-12-21 | Cephalosporin derivatives, its pharmaceutical formulation and method of use thereof |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0111934B1 (en) |
| JP (1) | JPS59130295A (en) |
| KR (1) | KR840007014A (en) |
| AT (1) | ATE36534T1 (en) |
| AU (1) | AU2281083A (en) |
| CA (1) | CA1235689A (en) |
| CS (1) | CS248714B2 (en) |
| DE (2) | DE3247613A1 (en) |
| DK (1) | DK594183A (en) |
| ES (1) | ES8406493A1 (en) |
| FI (1) | FI834711A (en) |
| GR (1) | GR79456B (en) |
| HU (1) | HU189793B (en) |
| IL (1) | IL70521A0 (en) |
| MA (1) | MA19984A1 (en) |
| NO (1) | NO834774L (en) |
| NZ (1) | NZ206660A (en) |
| PH (1) | PH21026A (en) |
| PT (1) | PT77878B (en) |
| ZA (1) | ZA839537B (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60169486A (en) * | 1984-02-10 | 1985-09-02 | Yamanouchi Pharmaceut Co Ltd | Preparation of 7-amino-3-substituted methyl-3-cephem-4- carboxylic acid and lower alkylsilyl derivative thereof |
| DE3650157T2 (en) * | 1985-12-26 | 1995-05-04 | Eisai Co Ltd | CEPHALOSPORINE COMPOUNDS. |
| IL84128A (en) * | 1986-10-13 | 1992-12-01 | Eisai Co Ltd | 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them |
| US4929612A (en) * | 1987-04-17 | 1990-05-29 | Eisai Co., Ltd. | Thiadiazolylacetamide cephem derivatives |
| DE3910421A1 (en) * | 1989-03-31 | 1990-10-04 | Hoechst Ag | POLAR CEPHALOSPORINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF |
| MX352760B (en) | 2011-09-09 | 2017-12-07 | Merck Sharp & Dohme Corp Star | Methods for treating intrapulmonary infections. |
| US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
| US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
| US20140275000A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Ceftolozane pharmaceutical compositions |
| US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
| MX2020004205A (en) | 2013-03-15 | 2021-11-16 | Merck Sharp & Dohme Llc | Ceftolozane antibiotic compositions. |
| WO2015035376A2 (en) | 2013-09-09 | 2015-03-12 | Calixa Therapeutics, Inc. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
| US20150094293A1 (en) | 2013-09-27 | 2015-04-02 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU536842B2 (en) * | 1978-12-29 | 1984-05-24 | Fujisawa Pharmaceutical Co., Ltd. | Cephalosporin antibiotics |
| DE3118732A1 (en) * | 1981-05-12 | 1982-12-02 | Hoechst Ag, 6000 Frankfurt | CEPHALOSPORINE DERIVATIVES AND METHOD FOR THEIR PRODUCTION |
-
1982
- 1982-12-23 DE DE19823247613 patent/DE3247613A1/en not_active Withdrawn
-
1983
- 1983-12-19 HU HU834333A patent/HU189793B/en unknown
- 1983-12-21 PH PH30018A patent/PH21026A/en unknown
- 1983-12-21 FI FI834711A patent/FI834711A/en not_active Application Discontinuation
- 1983-12-21 IL IL70521A patent/IL70521A0/en unknown
- 1983-12-21 KR KR1019830006057A patent/KR840007014A/en not_active Application Discontinuation
- 1983-12-21 DE DE8383112859T patent/DE3377714D1/en not_active Expired
- 1983-12-21 EP EP83112859A patent/EP0111934B1/en not_active Expired
- 1983-12-21 NZ NZ206660A patent/NZ206660A/en unknown
- 1983-12-21 ES ES528248A patent/ES8406493A1/en not_active Expired
- 1983-12-21 GR GR73321A patent/GR79456B/el unknown
- 1983-12-21 AT AT83112859T patent/ATE36534T1/en not_active IP Right Cessation
- 1983-12-22 CA CA000444077A patent/CA1235689A/en not_active Expired
- 1983-12-22 JP JP58243059A patent/JPS59130295A/en active Pending
- 1983-12-22 DK DK594183A patent/DK594183A/en not_active Application Discontinuation
- 1983-12-22 ZA ZA839537A patent/ZA839537B/en unknown
- 1983-12-22 NO NO834774A patent/NO834774L/en unknown
- 1983-12-22 AU AU22810/83A patent/AU2281083A/en not_active Abandoned
- 1983-12-22 CS CS839806A patent/CS248714B2/en unknown
- 1983-12-22 PT PT77878A patent/PT77878B/en unknown
- 1983-12-23 MA MA20205A patent/MA19984A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59130295A (en) | 1984-07-26 |
| AU2281083A (en) | 1984-06-28 |
| IL70521A0 (en) | 1984-03-30 |
| FI834711A0 (en) | 1983-12-21 |
| CS248714B2 (en) | 1987-02-12 |
| DE3377714D1 (en) | 1988-09-22 |
| MA19984A1 (en) | 1984-07-01 |
| CA1235689A (en) | 1988-04-26 |
| KR840007014A (en) | 1984-12-04 |
| ES528248A0 (en) | 1984-08-01 |
| NZ206660A (en) | 1987-07-31 |
| DK594183A (en) | 1984-06-24 |
| EP0111934B1 (en) | 1988-08-17 |
| DE3247613A1 (en) | 1984-07-05 |
| PT77878B (en) | 1986-04-21 |
| EP0111934A2 (en) | 1984-06-27 |
| EP0111934A3 (en) | 1985-05-15 |
| ATE36534T1 (en) | 1988-09-15 |
| HUT34035A (en) | 1985-01-28 |
| ZA839537B (en) | 1984-08-29 |
| FI834711A (en) | 1984-06-24 |
| ES8406493A1 (en) | 1984-08-01 |
| GR79456B (en) | 1984-10-30 |
| HU189793B (en) | 1986-07-28 |
| PT77878A (en) | 1984-01-01 |
| DK594183D0 (en) | 1983-12-22 |
| NO834774L (en) | 1984-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE802347L (en) | 7-acylamino-3-vinylcephalosporanic acid derivatives | |
| PH21026A (en) | Cephalosporin derivatives, its pharmaceutical formulation and method of use thereof | |
| PH20088A (en) | Cephalosporin derivatives,composition containing same and method of use thereof | |
| DE3474148D1 (en) | Cephalosporin derivatives and process for their preparation | |
| JPS54106495A (en) | Cephem derivative | |
| JPS5683494A (en) | Production of 7alpha-alkoxycephalosporin derivative |